S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
15 A.I. Trading Opportunities a Day (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Drought-struck Barcelona quenches thirst with costly desalination
15 A.I. Trading Opportunities a Day (Ad)
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Debt ceiling agreement gets thumbs up from business groups, jeers from some on political right
OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Forecast, Price & News

$0.87
0.00 (0.00%)
(As of 05/26/2023 08:48 PM ET)
Compare
Today's Range
$0.81
$0.87
50-Day Range
$0.84
$1.50
52-Week Range
$0.79
$2.20
Volume
9,400 shs
Average Volume
28,054 shs
Market Capitalization
$14.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PBIO stock logo

About Pressure BioSciences (OTCMKTS:PBIO) Stock

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

PBIO Stock News Headlines

Millionaire Trader Drops Bombshell… “The Only Trade You Will Ever Need”
“FORGET 99% of the Stock Market... Trade ONE Stock... ONCE Per Month – Over and Over Again!”
Millionaire Trader Drops Bombshell… “The Only Trade You Will Ever Need”
“FORGET 99% of the Stock Market... Trade ONE Stock... ONCE Per Month – Over and Over Again!”
See More Headlines
Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

PBIO Company Calendar

Last Earnings
4/12/2023
Today
5/28/2023
Next Earnings (Estimated)
8/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PBIO
Employees
12
Year Founded
N/A

Profitability

Net Income
$-16,080,000.00
Net Margins
-939.40%
Pretax Margin
-939.45%

Debt

Sales & Book Value

Annual Sales
$1.73 million
Book Value
($1.91) per share

Miscellaneous

Free Float
15,240,000
Market Cap
$14.82 million
Optionable
Not Optionable
Beta
0.71

Key Executives

  • Mr. Richard T. Schumacher (Age 73)
    Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director
    Comp: $355.18k
  • Dr. Alexander V. Lazarev Ph.D. (Age 58)
    Chief Science Officer
    Comp: $202.34k
  • Dr. Edmund Y. Ting Ph.D. (Age 68)
    Sc.D. Ph.D., Sr. VP of Engineering
    Comp: $256.92k
  • John B. Hollister
    Director of Sales & Marketing













PBIO Stock - Frequently Asked Questions

How have PBIO shares performed in 2023?

Pressure BioSciences' stock was trading at $1.30 on January 1st, 2023. Since then, PBIO stock has decreased by 33.1% and is now trading at $0.87.
View the best growth stocks for 2023 here
.

Are investors shorting Pressure BioSciences?

Pressure BioSciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,300 shares, an increase of 283.3% from the April 30th total of 600 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is currently 0.1 days.
View Pressure BioSciences' Short Interest
.

When is Pressure BioSciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 16th 2023.
View our PBIO earnings forecast
.

How were Pressure BioSciences' earnings last quarter?

Pressure BioSciences, Inc. (OTCMKTS:PBIO) posted its quarterly earnings data on Wednesday, April, 12th. The company reported ($0.37) EPS for the quarter. The company had revenue of $0.61 million for the quarter.

What other stocks do shareholders of Pressure BioSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS).

What is Pressure BioSciences' stock symbol?

Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO."

How do I buy shares of Pressure BioSciences?

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pressure BioSciences' stock price today?

One share of PBIO stock can currently be purchased for approximately $0.87.

How much money does Pressure BioSciences make?

Pressure BioSciences (OTCMKTS:PBIO) has a market capitalization of $14.82 million and generates $1.73 million in revenue each year. The company earns $-16,080,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.

How can I contact Pressure BioSciences?

Pressure BioSciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The official website for the company is www.pressurebiosciences.com. The company can be reached via phone at 508-230-1828, via email at ir@pressurebiosciences.com, or via fax at 508-230-1829.

This page (OTCMKTS:PBIO) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -